Cargando…
Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss
Autor principal: | Dirks, Marlou L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321888/ https://www.ncbi.nlm.nih.gov/pubmed/35415892 http://dx.doi.org/10.1113/JP282992 |
Ejemplares similares
-
The local mammalian target of rapamycin (mTOR) modulation: a promising strategy to counteract neurodegeneration
por: Dolcetta, Diego, et al.
Publicado: (2019) -
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies
por: Conte, Elena, et al.
Publicado: (2020) -
The impact of short-term forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers
por: Dirks, Marlou L., et al.
Publicado: (2023) -
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice
por: Higashihara, Takaaki, et al.
Publicado: (2021) -
Skeletal muscle activity and CNS neuro-plasticity
por: Zhorne, Rachel, et al.
Publicado: (2016)